Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate whether early life natural exposure to fatty acid affects the AD risk.


Clinical Trial Description

The prevalence of Allergic Diseases (AD) is rising dramatically worldwide especially in more industrialized countries during the past two decades, representing a substantial disease burden of individuals and health service cost. Early life nutritional exposures could modify the gene expression and susceptibility of allergic diseases (AD), yet the effects of early life polyunsaturated fatty acids (PUFA) and ruminant trans fatty acids (R-TFA) on AD remain unclear.Therefore,the investigators performed the meta-analysis and systematic review to evaluate whether early life natural exposure to PUFA and R-TFA affects the AD risk. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03344783
Study type Observational
Source Sun Yat-sen University
Contact
Status Completed
Phase N/A
Start date March 15, 2017
Completion date October 10, 2017

See also
  Status Clinical Trial Phase
Completed NCT03721263 - Study of ASLAN004 in Healthy Subjects Phase 1
Completed NCT03922087 - No-worry Baby Project
Recruiting NCT04189978 - Impact of Microbial Exposure of the Habitat at the Time of Birth on the Development of Allergic Diseases.
Completed NCT05442658 - Importance and Association of Gut Microbiota and Biochemical Metabolites on Children Allergic Disorder